Samsung Biologics, Foreign Investors Net Buy 15,389 Shares... Stock Price Up 5.01%
Samsung Biologics ranked among the top searched stocks on 2 days within the past month.
As of 1:31 PM on the 4th, Samsung Biologics is trading at 734,000 KRW, up 5.01% from the previous day. This represents a 16.51% increase compared to October 26. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners have net purchased 15,389 shares of Samsung Biologics, and institutions have net purchased 9,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 102,116 shares, while foreigners and institutions have net sold 4,497 shares and net purchased 106,505 shares, respectively.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- Court Partially Grants Samsung Electronics' Injunction to Prohibit Industrial Action... 100 Million Won Penalty Per Day for Violations
- [US-China Summit] China to Purchase $17 Billion in US Agricultural Products Annually...Real Gains for Beijing
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
